Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/13769

D-Limonene: Target Organs and Levels of Evidence for TR-347

Toxicology and Carcinogenesis Studies of d-Limonene (CASRN 5989-27-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies)

Chemical (Study Title)
CASRN
Peer Review DateRoute/Exposure LevelsStudy Laboratory
D-Limonene
5989-27-5
04/18/1988Gavage
FR: 0,300,600, MR: 0,75,150, FM: 0,500,1000, MM: 0,250,500 MG/KG/50 PER GROUP
BioReliance, Inc

Levels of Evidence

Male Rats: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Kidney Tubular Cell: ADENOMA 0/50 4/50 8/50 OR ADENOCARCINOMA 0/50 4/50 3/50
Non-Neoplastic Lesions
  • KIDNEY: PAPILLA, MINERALIZATION 7/50 43/50 48/50; HYPERPLASIA, TUBULAR CELL 0/50 4/50 7/50; HYPERPLASIA, EPITHELIAL 0/50 35/50 43/50; INCREASED SEVERITY OF NEPHROPATHY
Female Rats: No Evidence
Male Mice: No Evidence
Female Mice: No Evidence